Skip to main content

Adaptimmune Therapeutics PLC

ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001621227

No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q1 2025

Institutional positions in Adaptimmune Therapeutics PLC as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
67
−11 vs. Q4 2024
Shares held
116.1M
−8.32M (−6.7%) vs. Q4 2024
Total value
$22.9M
−$44.2M (−65.9%) vs. Q4 2024
New holders
8
17 more added
Sold out
19
16 more reduced

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADAPY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 67 institutions
Q1 2021: 84 institutionsQ2 2021: 82 institutionsQ3 2021: 92 institutionsQ4 2021: 85 institutionsQ1 2022: 80 institutionsQ2 2022: 77 institutionsQ3 2022: 68 institutionsQ4 2022: 69 institutionsQ1 2023: 65 institutionsQ2 2023: 89 institutionsQ3 2023: 79 institutionsQ4 2023: 79 institutionsQ1 2024: 80 institutionsQ2 2024: 76 institutionsQ3 2024: 81 institutionsQ4 2024: 80 institutionsQ1 2025: 67 institutionsQ2 2025: 65 institutionsQ3 2025: 55 institutionsQ4 2025: 10 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ1 2025: $22.9M
Q1 2021: $623.8MQ2 2021: $475.7MQ3 2021: $577.3MQ4 2021: $425.9MQ1 2022: $229.2MQ2 2022: $195.1MQ3 2022: $122.4MQ4 2022: $166.3MQ1 2023: $126.4MQ2 2023: $133.9MQ3 2023: $115.7MQ4 2023: $113.9MQ1 2024: $256.1MQ2 2024: $150.0MQ3 2024: $144.1MQ4 2024: $67.0MQ1 2025: $22.9MQ2 2025: $27.7MQ3 2025: $5.47MQ4 2025: $79.7KQ1 2026: $72Q2 2026: $0
Institutions holding ADAPY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$72
Q4 202510$79.7K
Q3 202555$5.47M
Q2 202565$27.7M
Q1 202567$22.9M
Q4 202480$67.0M
Q3 202481$144.1M
Q2 202476$150.0M
Q1 202480$256.1M
Q4 202379$113.9M
Q3 202379$115.7M
Q2 202389$133.9M
Q1 202365$126.4M
Q4 202269$166.3M
Q3 202268$122.4M
Q2 202277$195.1M
Q1 202280$229.2M
Q4 202185$425.9M
Q3 202192$577.3M
Q2 202182$475.7M
Q1 202184$623.8M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Adaptimmune Therapeutics PLC; share changes are against Q4 2024.

Institutions holding ADAPY in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Danske Bank A/S1$00.00%00.0%Unchanged
SBI Securities Co., Ltd.10$20.00%+10New
TD Waterhouse Canada Inc.14$40.00%00.0%Unchanged
Farther Finance Advisors, LLC20$50.00%+20New
Investors Research Corp100$200.00%00.0%Unchanged
Group One Trading, L.P.147$290.00%−20,368−99.3%Reduced
Transce3nd, LLC175$340.00%00.0%Unchanged
BNP Paribas Arbitrage, SA213$420.00%00.0%Unchanged
Parallel Advisors, LLC250$490.00%00.0%Unchanged
HighMark Wealth Management LLC287$570.00%00.0%Unchanged
Bryn Mawr Trust Co604$1190.00%00.0%Unchanged
Raiffeisen Bank International AG907$1810.00%00.0%Unchanged
Plante Moran Financial Advisors, LLC925$1820.00%00.0%Unchanged
Sandy Spring Bank1,050$2070.00%00.0%Unchanged
CIBC Private Wealth Group, LLC3,023$6820.00%00.0%Unchanged
Lindbrook Capital, LLC4,610$9080.00%00.0%Unchanged
IFG Advisory, LLC10,000$1.97K0.00%+10,000New
Qube Research & Technologies Ltd10,113$1.99K0.00%+10,113New
X-Square Capital, LLC11,173$2.00K0.00%00.0%Unchanged
Ausdal Financial Partners, Inc.12,476$2.46K0.00%+12,476New
Goldman Sachs Group Inc16,149$3.18K0.00%−11−0.1%Reduced
Susquehanna International Group, LLP17,344$3.42K0.00%−11,806−40.5%Reduced
Rhumbline Advisers18,313$3.60K0.00%−1,435−7.3%Reduced
Prosperity Wealth Management, Inc.19,798$3.90K0.00%−2,072−9.5%Reduced
Tower Research Capital LLC (TRC)21,966$4.33K0.00%+2,436+12.5%Added
Raymond James Financial Inc25,261$4.98K0.00%−5,820−18.7%Reduced
HSBC Holdings PLC26,064$5.21K0.00%00.0%Unchanged
Stifel Financial Corp26,469$5.21K0.00%00.0%Unchanged
Wealth Enhancement Advisory Services, LLC26,816$5.28K0.00%00.0%Unchanged
Newman Dignan & Sheerar, Inc.27,957$5.51K0.00%00.0%Unchanged
Simon Quick Advisors, LLC30,000$5.91K0.00%00.0%Unchanged
CSS LLC30,702$6.05K0.00%00.0%Unchanged
Columbia Advisory Partners LLC36,530$7.20K0.01%+20,110+122.5%Added
Wells Fargo & Company40,700$8.02K0.00%−23,267−36.4%Reduced
Barclays PLC50,068$9.86K0.00%+70.0%Added
Northern Trust Corp51,333$10.1K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec53,186$10.5K0.00%+52,431+6,944.5%Added
State of New Jersey Common Pension Fund D54,718$10.8K0.00%+54,718New
SEI Investments Co54,824$10.8K0.00%+54,824New
Advisor Group Holdings, Inc.65,058$13.0K0.00%+38,500+145.0%Added
State of Tennessee, Treasury Department73,376$14.5K0.00%+73,376New
Invesco Ltd.78,031$15.4K0.00%+14,696+23.2%Added
Captrust Financial Advisors80,609$15.9K0.00%−1,020−1.2%Reduced
Graham Capital Management, L.P.87,274$17.2K0.00%+50,079+134.6%Added
Millennium Management LLC94,283$18.6K0.00%+64,724+219.0%Added
Geode Capital Management, LLC109,066$21.5K0.00%−30,735−22.0%Reduced
Two Sigma Investments, LP135,947$26.8K0.00%+59,600+78.1%Added
Key Client Fiduciary Advisors, LLC150,150$29.6K0.01%−105,209−41.2%Reduced
BlackRock, Inc.183,686$36.2K0.00%00.0%Unchanged
Two Sigma Advisers, LP206,732$40.7K0.00%+135,997+192.3%Added
Clear Harbor Asset Management, LLC240,725$47.4K0.00%+222,200+1,199.5%Added
State Street Corp421,292$83.0K0.00%+21,213+5.3%Added
Rathbone Brothers plc432,818$85.3K0.00%00.0%Unchanged
JPMorgan Chase & Co882,331$173.8K0.00%−34,610−3.8%Reduced
UBS Group AG1,012,740$199.5K0.00%+870,996+614.5%Added
Bank of America Corp1,147,013$226.0K0.00%−1,715,317−59.9%Reduced
FMR LLC1,754,889$345.7K0.00%−9,617−0.5%Reduced
Renaissance Technologies LLC1,813,860$357.3K0.00%−712,664−28.2%Reduced
Acadian Asset Management LLC2,218,215$424.0K0.00%+1,707,999+334.8%Added
Rock Springs Capital Management LP2,483,468$489.2K0.03%00.0%Unchanged
Morgan Stanley2,715,947$535.0K0.00%+1,391,083+105.0%Added
MPM Oncology Impact Management LP4,894,344$964.2K0.17%−201,568−4.0%Reduced
MPM Asset Management LLC5,335,715$1.05M1.51%−219,746−4.0%Reduced
NEA Management Company, LLC17,079,778$3.36M0.26%00.0%Unchanged
Two Seas Capital LP20,529,685$4.04M0.63%+5,694,539+38.4%Added
Long Focus Capital Management, LLC23,756,687$4.68M0.32%+3,262,294+15.9%Added
EcoR1 Capital, LLC27,404,070$5.40M0.32%00.0%Unchanged
Baillie Gifford & Co0$00.00%−11,819,095−100.0%Sold out
PFM Health Sciences, LP0$00.00%−4,871,969−100.0%Sold out
Redmile Group, LLC0$00.00%−715,607−100.0%Sold out
Marshall Wace, LLP0$00.00%−529,123−100.0%Sold out
Jane Street Group, LLC0$00.00%−326,937−100.0%Sold out
LPL Financial LLC0$00.00%−183,479−100.0%Sold out
Citadel Advisors LLC0$00.00%−175,052−100.0%Sold out
Virtu Financial LLC0$00.00%−122,696−100.0%Sold out
HRT Financial LP0$00.00%−83,199−100.0%Sold out
Palisades Investment Partners, LLC0$00.00%−47,114−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−43,000−100.0%Sold out
Oppenheimer & Co Inc0$00.00%−32,043−100.0%Sold out
Hunter Associates Investment Management LLC0$00.00%−22,000−100.0%Sold out
Kingswood Wealth Advisors, LLC0$00.00%−18,690−100.0%Sold out
PKS Advisory Services, LLC0$00.00%−17,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−16,563−100.0%Sold out
Baader Bank INC0$00.00%−18,095−100.0%Sold out
R Squared Ltd0$00.00%−8,770−100.0%Sold out
IFP Advisors, Inc0$00.00%−3,023−100.0%Sold out
Legacy Capital Wealth Management, LLC––––Not filed
Global Retirement Partners, LLC––––Not filed